Literature DB >> 31509684

Canagliflozin and Renal Outcomes in Diabetic Nephropathy.

Adrian Post1, Michele F Eisenga1, Stephan J L Bakker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31509684     DOI： 10.1056/NEJMc1909687

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Oat β Glucan Ameliorates Renal Function and Gut Microbiota in Diabetic Rats.

Authors:  Ruoyu Wang; Zhaofeng Zhang; Sumiya Aihemaitijiang; Chen Ye; Mairepaiti Halimulati; Xiaojie Huang; Haoyuan Qin
Journal:  Front Nutr       Date:  2022-05-09

2.  Ertugliflozin, renoprotection and potential confounding by muscle wasting.

Authors:  Dion Groothof; Adrian Post; Reinold O B Gans; Stephan J L Bakker
Journal:  Diabetologia       Date:  2021-12-23       Impact factor: 10.122

3.  Sodium-Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?

Authors:  Adrian Post; Dion Groothof; Michele F Eisenga; Stephan J L Bakker
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.